Graft-versus-host disease


00:00 / 00:00



Graft-versus-host disease

Immune system

General infections


Neonatal sepsis


Hypersensitivity reactions

Type I hypersensitivity

Food allergy



Type II hypersensitivity

Immune thrombocytopenic purpura

Autoimmune hemolytic anemia

Hemolytic disease of the newborn

Goodpasture syndrome

Rheumatic heart disease

Myasthenia gravis

Graves disease

Pemphigus vulgaris

Type III hypersensitivity

Serum sickness

Systemic lupus erythematosus

Poststreptococcal glomerulonephritis

Type IV hypersensitivity

Graft-versus-host disease

Contact dermatitis


Transplant rejection

Graft-versus-host disease

Cytomegalovirus infection after transplant (NORD)

Post-transplant lymphoproliferative disorders (NORD)


X-linked agammaglobulinemia

Selective immunoglobulin A deficiency

Common variable immunodeficiency

IgG subclass deficiency

Hyperimmunoglobulin E syndrome

Isolated primary immunoglobulin M deficiency

Thymic aplasia

DiGeorge syndrome

Severe combined immunodeficiency

Adenosine deaminase deficiency


Hyper IgM syndrome

Wiskott-Aldrich syndrome

Leukocyte adhesion deficiency

Chediak-Higashi syndrome

Chronic granulomatous disease

Complement deficiency

Hereditary angioedema


Immune system organ disorders


Ruptured spleen

Immune system pathology review

Blood transfusion reactions and transplant rejection: Pathology review

Immunodeficiencies: T-cell and B-cell disorders: Pathology review

Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review

Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review


Graft-versus-host disease


0 / 8 complete

High Yield Notes

3 pages


Graft-versus-host disease

of complete

External References

First Aid









graft-versus-host disease p. 117

Graft-versus-host disease p. 117

type IV hypersensitivity p. 111


graft-versus-host disease p. 117

Jaundice p. 402

graft-versus-host disease p. 117

Maculopapular rash

graft-versus-host disease p. 117

Type IV hypersensitivity p. 111

graft-versus-host disease p. 117


Content Reviewers

Rishi Desai, MD, MPH


Kaia Chessen, MScBMC

Gil McIntire

With “graft-versus-host disease”, “graft” refers to a section of transplanted, or donated tissue, like bone marrow or peripheral blood, and “host” refers to the tissues of the person receiving the transplant.

In graft versus host disease, immune cells in the donated tissue attack the recipient’s body cells.

Normally, the immune system’s job is to fight against anything foreign that might cause harm, without harming the body’s own cells.

To make that work, the immune system cells are trained, from early on, to distinguish non-self or foreign, from self.

Recognizing whether a cell is non-self or self involves a set of genes called histocompatibility genes, which make up the major histocompatibility complex, or MHC proteins.

These MHC proteins also go by the name human leukocyte antigens, or HLA.

The histocompatibility genes actually code for two classes of proteins, MHC class I and MHC class II.

MHC class I molecules are found on all nucleated cells throughout the body, while MHC class II molecules are only expressed on antigen presenting cells like monocytes, macrophages, dendritic cells, and B cells.

But because the genes coding for them are so variable in the population, two different individuals will have major differences in the antigens expressed on their cells, even siblings - unless, of course, they’re identical twins.

When there’s a tissue transplantation, the transplant usually comes from a genetically different individual, and it’s called an allograft.

If there are immune cells within that allograft, they will see the MHC proteins that coat every cell of the recipient body as “non-self”.

In fact, that’s why transplantation donors are really carefully selected, to make sure that they share as many of the same HLA antigens with the host as possible.

But even between HLA-identical individuals, other antigens, called minor histocompatibility antigens, can be recognized as foreign and trigger an immune response between the donor and the recipient.


Graft-versus-host disease (GVHD) is an immunological reaction associated with transplantation, which occurs when T cells in the graft tissue react against the tissues of the graft recipient. It is commonly seen in hematopoietic stem-cell transplantation recipients and presents with symptoms like skin rashes, diarrhea, and liver damage.


  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma" The Korean Journal of Hematology (2011)
  7. "Acute graft versus host disease" Orphanet Journal of Rare Diseases (2007)

Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.